Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06282887
Other study ID # 2021-IIT-002
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 9, 2021
Est. completion date November 10, 2024

Study information

Verified date February 2024
Source Guangzhou Concord Cancer Center
Contact Yinglan He
Phone 18320739030
Email wing_____5@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to examine the effects of a music therapy protocol on improving anxiety, symptom distress, and relaxation among cancer patients who are going through MRI scanning. Physiological data, such as pulse rates and respiration rates will be collected. Furthermore, data about scanning efficiency will be collected to assess if scanning efficiency is affected by the protocol implementation. The secondary study objective is to assess whether or not there is a relationship between patient attention to music during the intervention process and the changes in anxiety, symptom distress, and relaxation.


Description:

To assess the protocol, recruited participants will be randomly allocated into two groups: a control group or a music therapy group. Participants in the control group will receive standard care as usual, and they will be offered music therapy interventions upon their request during subsequent appointments. Participants in the music group will receive standard care and music therapy interventions. All participants will rate their psychological states pre- and post-MRI exams. Their physiological data will be recorded during the examination. After the scanning, they will complete an experience review.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date November 10, 2024
Est. primary completion date November 10, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: 1. The subject is diagnosed with cancer; 2. The subject is between 18- 60 years old; 3. The subject understands Mandarin, Cantonese, or English; 4. The subject did not use medication for sedatives, anxiolytics, and/or sleep aids; 5. The subject is awake without cognitive disorders; 6. the subject rates more than 0 on the 0-10 VAS for anxiety; 7. The subject has finished primary school level education. Exclusion Criteria: 1. The subject withdraws the MRI scan; 2. The subject needs other intervention(s) to complete the scan; 3. The subject has hearing and/or visual impairments; 4. The subject has a history of a severe somatic psychiatric disease or clinically diagnosed mental disorders.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Music therapy
The intervention has two parts. The first part is an approximately 15-minute music therapy session to induce relaxation and positive memories attached to the relaxing live music provided by a credentialed music therapist. The second part is music listening during the scanning process.

Locations

Country Name City State
China GuangZhou Concord Cancer Center Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Guangzhou Concord Cancer Center

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety Self-rating scale (VAS 0-10) to rate patient anxiety, with 0 being no anxiety and 10 being extreme anxious From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 2 days
Primary Symptom distress Self-rating scale (VAS 0-10) to rate symptom distress, with 0 being no distress and 10 being extreme distressed. From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 2 days
Primary Relaxation Self-rating scale (VAS 0-10) to rate relaxation, with 0 being unrelaxed and 10 being very relaxed. From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 2 days
Secondary Pulse rates The change of pulse rates during MRI scanning From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 1 day
Secondary Respiration rate The change of respiration rate during MRI scanning From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Secondary Scanning efficiency Duration of actual scans require, duration of the whole process, and the frequency of pause due to patient in-compliance From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Secondary Patient satisfaction level A 1 to 5 satisfaction scale, with 1 being strongly unsatisfied, 2 being unsatisfied, 3 being somewhere between unsatisfied and satisfied, 4 being quite satisfied. and 5 being strongly satisfied From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 3 days
Secondary Patient attention to music (only for the music therapy group) A 1 to 5 self-rating scale, with 1 being fully attended during the whole process, 2 being attended most time during scanning, 3 being attended sometime during scanning, 4 being unattended most time during scanning, and 5 being fully unattended From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 3 days
See also
  Status Clinical Trial Phase
Completed NCT05571098 - The Effects of Nurse Navigation Program on Symptom Management and Psychosocial Adjustment in Colorectal Cancer Patients N/A
Recruiting NCT05667857 - Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy N/A
Recruiting NCT04638699 - Optimized Psycho-oncological Care Through an Interdisciplinary Care Algorithm N/A